Rivaroxaban AET 15mg, film-coated tablets Malta - englanti - Medicines Authority

rivaroxaban aet 15mg, film-coated tablets

alfred e. tiefembacher (gmbh &co. kg) van-der-smissen-straße 1, 22767 hamburg, germany - rivaroxaban - film-coated tablet - rivaroxaban 15 mg - antithrombotic agents

Rivaroxaban AET 20mg, film-coated tablets Malta - englanti - Medicines Authority

rivaroxaban aet 20mg, film-coated tablets

alfred e. tiefembacher (gmbh &co. kg) van-der-smissen-straße 1, 22767 hamburg, germany - rivaroxaban - film-coated tablet - rivaroxaban 20 mg - antithrombotic agents

RIVAROXABAN TARO 10 MG Israel - englanti - Ministry of Health

rivaroxaban taro 10 mg

taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 10 mg - rivaroxaban - * prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.* prevention of recurrent deep vein thrombosis (dvt) and pulmonary embolism (pe), in adults (following completion of at least 6 months therapy for dvt or pe).

RIVAROXABAN TARO 15 MG Israel - englanti - Ministry of Health

rivaroxaban taro 15 mg

taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 15 mg - rivaroxaban - paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

RIVAROXABAN TARO 20 MG Israel - englanti - Ministry of Health

rivaroxaban taro 20 mg

taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 20 mg - rivaroxaban - * prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack.* treatment of deep vein thrombosis (dvt), and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Rivaroxaban PharOS 2.5mg film-coated Tablets Malta - englanti - Medicines Authority

rivaroxaban pharos 2.5mg film-coated tablets

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - rivaroxaban - film-coated tablet - rivaroxaban 2.5 mg - antithrombotic agents

Rivaroxaban PharOS 10mg film-coated Tablets Malta - englanti - Medicines Authority

rivaroxaban pharos 10mg film-coated tablets

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - rivaroxaban - film-coated tablet - rivaroxaban 10 mg - antithrombotic agents

Rivaroxaban PharOS 15mg film-coated Tablets Malta - englanti - Medicines Authority

rivaroxaban pharos 15mg film-coated tablets

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - rivaroxaban - film-coated tablet - rivaroxaban 15 mg - antithrombotic agents

Rivaroxaban PharOS 20mg film-coated Tablets Malta - englanti - Medicines Authority

rivaroxaban pharos 20mg film-coated tablets

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - rivaroxaban - film-coated tablet - rivaroxaban 20 mg - antithrombotic agents

Rivaroxaban PharOS 15mg / Rivaroxaban PharOS 20mg  film-coated Tablets Malta - englanti - Medicines Authority

rivaroxaban pharos 15mg / rivaroxaban pharos 20mg film-coated tablets

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - rivaroxaban - film-coated tablet - rivaroxaban 15 mg rivaroxaban 20 mg - antithrombotic agents